67537-1-Ig

antibody from Proteintech Group

Targeting: KLRB1 CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

67537-1-Ig

Provider

Proteintech Group

Product name

KLRB1/CD161 antibody

Antibody type

Monoclonal

Description

KLRB1/CD161 antibody (Cat. #67537-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

3D8F5

Vial size

20ul, 150ul

References

Submitted references

IL-17A-Exposed Senescent Fibroblasts Evade Apoptosis and Clearance.

Ogata Y, Yamada T, Ishii Y, Arima M, Iwata Y, Hasegawa S, Sugiura K, Akamatsu H
Experimental dermatology 2026 Feb;35(2):e70225

---

Identification of Diagnostic Biomarkers Associated With M1 Macrophage in Lung Squamous Cell Carcinoma via Machine Learning.

Deng H, Wang Z, Zhang Q
Frontiers in bioscience (Landmark edition) 2025 Oct 31;30(10):44661

---

Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer.

Hou Q, Li C, Chong Y, Yin H, Guo Y, Yang L, Li T, Yin S
Frontiers in immunology 2024;15:1460607

---

Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis.

Ma Z, An P, Hao S, Huang Z, Yin A, Li Y, Tian J
Frontiers in immunology 2024;15:1374763

---

Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma.

Hu X, Dong Y, Xie S, Song Y, Yu C, He Y, Wang Z, Hu Q, Ni Y, Ding L
The journal of pathology. Clinical research 2024 Mar;10(2):e353

---

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway.

Xu S, Xu Y, Chai W, Liu X, Li J, Sun L, Pan H, Yan M
Journal of thoracic disease 2024 Jun 30;16(6):3764-3781

---

Distinctive multicellular immunosuppressive hubs confer different intervention strategies for left- and right-sided colon cancers.

Liu B, Li S, Cheng Y, Song P, Xu M, Li Z, Shao W, Xin J, Fu Z, Gu D, Du M, Zhang Z, Wang M
Cell reports. Medicine 2024 Jun 18;5(6):101589

---

Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer.

Huang G, Xiao S, Jiang Z, Zhou X, Chen L, Long L, Zhang S, Xu K, Chen J, Jiang B
Frontiers in endocrinology 2023;14:1185799

---

Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma.

Lu H, Qian J, Cheng L, Shen Y, Chu T, Zhao C
BMJ open respiratory research 2023 Dec 11;10(1)